| Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naïve patients: a statewide retrospective cohort study RA Deyo, SE Hallvik, C Hildebran, M Marino, E Dexter, JM Irvine, ... Journal of general internal medicine 32, 21-27, 2017 | 338 | 2017 |
| Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and nonusers RA Deyo, SE Hallvik, C Hildebran, M Marino, R Springer, JM Irvine, ... The Journal of Pain 19 (2), 166-177, 2018 | 65 | 2018 |
| Clinicians’ use of prescription drug monitoring programs in clinical practice and decision-making GJ Leichtling, JM Irvine, C Hildebran, DJ Cohen, SE Hallvik, RA Deyo Pain medicine 18 (6), 1063-1069, 2017 | 56 | 2017 |
| The impacts of COVID-19 on mental health, substance use, and overdose concerns of people who use drugs in rural communities E Stack, G Leichtling, JE Larsen, M Gray, J Pope, JM Leahy, L Gelberg, ... Journal of addiction medicine 15 (5), 383-389, 2021 | 46 | 2021 |
| High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program–based proactive alerts P Geissert, S Hallvik, J Van Otterloo, N O'Kane, L Alley, J Carson, ... Pain 159 (1), 150-156, 2018 | 46 | 2018 |
| “Like Yin and Yang”: perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities R Baker, G Leichtling, C Hildebran, C Pinela, EN Waddell, C Sidlow, ... Journal of addiction medicine 15 (1), 34-39, 2021 | 43 | 2021 |
| Patient outcomes after opioid dose reduction among patients with chronic opioid therapy SE Hallvik, S El Ibrahimi, K Johnston, J Geddes, G Leichtling, PT Korthuis, ... Pain 163 (1), 83-90, 2022 | 41 | 2022 |
| Association of methamphetamine and opioid use with nonfatal overdose in rural communities PT Korthuis, RR Cook, CA Foot, G Leichtling, JI Tsui, TJ Stopka, J Leahy, ... JAMA network open 5 (8), e2226544-e2226544, 2022 | 33 | 2022 |
| Peer recovery support services across the continuum: In community, hospital, corrections, and treatment and recovery agency settings–A narrative review E Stack, C Hildebran, G Leichtling, EN Waddell, JM Leahy, E Martin, ... Journal of addiction medicine 16 (1), 93-100, 2022 | 32 | 2022 |
| Buprenorphine coverage in the Medicare Part D program for 2007 to 2018 DM Hartung, K Johnston, J Geddes, G Leichtling, KC Priest, PT Korthuis JAMA 321 (6), 607-609, 2019 | 32 | 2019 |
| Harm reduction and adaptations among PWUD in rural Oregon during COVID-19 A Seaman, G Leichtling, E Stack, M Gray, J Pope, JE Larsen, JM Leahy, ... AIDS and Behavior 25, 1331-1339, 2021 | 26 | 2021 |
| Clinical styles and practice policies: Influence on communication with patients regarding worrisome prescription drug monitoring program data C Hildebran, G Leichtling, JM Irvine, DJ Cohen, SE Hallvik, RA Deyo Pain Medicine 17 (11), 2061-2066, 2016 | 21 | 2016 |
| Adolescents in treatment: Effects of parental substance abuse on treatment entry characteristics and outcomes G Leichtling, RM Gabriel, CK Lewis, KJV Ley Journal of Social Work Practice in the Addictions 6 (1-2), 155-174, 2006 | 17 | 2006 |
| Physician responses to enhanced prescription drug monitoring program profiles G Leichtling, C Hildebran, K Novak, L Alley, S Doyle, C Reilly, SG Weiner Pain Medicine 21 (2), e9-e21, 2020 | 16 | 2020 |
| Preparing a prescription drug monitoring program data set for research purposes N O'Kane, SE Hallvik, M Marino, J Van Otterloo, C Hildebran, G Leichtling, ... Pharmacoepidemiology and drug safety 25 (9), 993-997, 2016 | 16 | 2016 |
| Using community surveys to inform the planning and implementation of environmental change strategies: Participatory research in 12 Washington communities RM Gabriel, GJ Leichtling, M Bolan, LG Becker American journal of community psychology 51, 243-253, 2013 | 16 | 2013 |
| Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in … TC Green, J Bratberg, AN Irwin, J Boggis, M Gray, G Leichtling, D Bolivar, ... Substance abuse 43 (1), 901-905, 2022 | 15 | 2022 |
| Prescription opioid dispensing patterns prior to heroin overdose in a state medicaid program: a case-control study DM Hartung, KA Johnston, S Hallvik, G Leichtling, J Geddes, C Hildebran, ... Journal of general internal medicine 35, 3188-3196, 2020 | 14 | 2020 |
| Research to support optimization of prescription drug monitoring programs S Doyle, G Leichtling, C Hildebran, C Reilly Pharmacoepidemiology and Drug Safety 26 (11), 1425-1427, 2017 | 11 | 2017 |
| “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply SS Shin, K LaForge, E Stack, J Pope, G Leichtling, JE Larsen, JM Leahy, ... Harm reduction journal 19 (1), 76, 2022 | 10 | 2022 |
